Literature DB >> 6748012

Homozygosity for autosomal dominant Marfan syndrome.

J Chemke, R Nisani, A Feigl, R Garty, M Cooper, Y Bårash, D Duksin.   

Abstract

Marfan syndrome is an autosomal dominant condition with varying phenotypic manifestations. Affected persons are usually heterozygotes. A family is presented in which the gene for this syndrome is segregating in a large number of members. Two sibs suffered from unusually severe, identical, and fatal manifestations from birth, their parents having mild cardiovascular and somatic symptoms common in Marfan syndrome. Investigation of collagen biosynthesis in fibroblasts revealed no abnormalities in fibronectin and procollagen I and III synthesis and secretion or in the procollagen to collagen conversion. We suggest that these two sibs are examples of homozygosity for the Marfan syndrome gene, based on the large number of affected members, the absence of additional consanguinity, manifestation of the syndrome in both parents, and the severity of the disease in the two sibs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6748012      PMCID: PMC1049260          DOI: 10.1136/jmg.21.3.173

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  Skin collagen in idiopathic adolescent scoliosis and Marfan's syndrome.

Authors:  M J Francis; M C Sanderson; R Smith
Journal:  Clin Sci Mol Med       Date:  1976-11

2.  Letter: Collagen of Marfan syndrome is abnormally soluble.

Authors:  R E Priest; J F Moinuddin; J H Priest
Journal:  Nature       Date:  1973-10-05       Impact factor: 49.962

3.  The production of lysyl oxidase by human fibroblasts in culture.

Authors:  D L Layman; A S Narayanan; G R Martin
Journal:  Arch Biochem Biophys       Date:  1972-03       Impact factor: 4.013

4.  The accumulation of hyaluronic acid in cultured fibroblasts of the Marfan syndrome.

Authors:  R Matalon; A Dorfman
Journal:  Biochem Biophys Res Commun       Date:  1968-07-26       Impact factor: 3.575

5.  Synthesis and degradation of hyaluronic acid in the cultured fibroblasts of Marfan's disease.

Authors:  S I Lamberg; A Dorfman
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

6.  Collagen metabolism of the skin in Marfan's syndrome.

Authors:  O Laitinen; J Uitto; M Iivanainen; M Hannuksela; K I Kivirikko
Journal:  Clin Chim Acta       Date:  1968-09       Impact factor: 3.786

7.  Relationship of the structure and biological activity of the natural homologues of tunicamycin.

Authors:  D Duksin; W C Mahoney
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

8.  Marfan syndrome: abnormal alpha 2 chain in type I collagen.

Authors:  P H Byers; R C Siegel; K E Peterson; D W Rowe; K A Holbrook; L T Smith; Y H Chang; J C Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Impaired conversion of procollagen to collagen by fibroblasts and bone treated with tunicamycin, an inhibitor of protein glycosylation.

Authors:  D Duksin; P Bornstein
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

10.  Case report and study of collagen metabolism in Marfan's syndrome.

Authors:  R Halbritter; M Aumailley; R Rackwitz; T Krieg; P K Müller
Journal:  Klin Wochenschr       Date:  1981-01-15
View more
  5 in total

1.  Marfan syndrome: absence of type I or III collagen structural defects in 25 patients.

Authors:  V R Harley; D Chan; J G Rogers; W G Cole
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Megalocornea. Clinical and genetic aspects.

Authors:  F M Meire
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

3.  A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype.

Authors:  L Karttunen; M Raghunath; L Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

4.  Neonatal Marfan syndrome with congenital arachnodactyly, flexion contractures, and severe cardiac valve insufficiency.

Authors:  I M Buntinx; P J Willems; S E Spitaels; P J Van Reempst; A M De Paepe; J E Dumon
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

5.  The clinical spectrum of missense mutations of the first aspartic acid of cbEGF-like domains in fibrillin-1 including a recessive family.

Authors:  Yvonne Hilhorst-Hofstee; Marry E B Rijlaarsdam; Arthur J H A Scholte; Marietta Swart-van den Berg; Michel I M Versteegh; Iris van der Schoot-van Velzen; Hans-Joachim Schäbitz; Emilia K Bijlsma; Marieke J Baars; Wilhelmina S Kerstjens-Frederikse; Jacques C Giltay; Ben C Hamel; Martijn H Breuning; Gerard Pals
Journal:  Hum Mutat       Date:  2010-12       Impact factor: 4.878

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.